News
GSE Wins Multi-Year Deal with One of the Largest US Oil Companies for Virtual Workforce Development Solution
GSE Systems, Inc. (“GSE Solutions” or “GSE”) (Nasdaq: GVP), a leader in delivering and supporting end-to-end training, engineering, compliance, simulation, and workforce solutions to the power and
Columbia Care Recognized in Top 1% on the Growjo 10,000 - The Fastest Growing Companies in the World List
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) has announced today that it has been named to the top 1% of the Growjo 10,000 - The Fastest
St. Luke’s University Health Network Wins 2020 Premier Alliance Excellence Award
Premier Inc. (NASDAQ: PINC) has named St. Luke’s University Health Network, a fully integrated, nationally recognized health network serving Pennsylvania and New Jersey, the winner of the 2020
HyreCar Selects Aon as Its Risk Management Partner
HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for ridesharing and delivery, today announced that Aon (NYSE: AON), a leading global professional services firm providing a broad range of
AMN CEO Susan Salka Named One of Modern Healthcare’s 100 Most Influential People of 2020
Susan Salka, President and CEO of AMN Healthcare (NYSE:AMN), has been named by Modern Healthcare as one of 2020’s 100 Most Influential People. This year’s list focused on people who influenced the
The Roku Channel Makes it Easy to Watch Free and Unlocked Entertainment and Debuts iHeartRadio Holiday Music Channels for “Winter StreamLand”
Roku, Inc. (NASDAQ: ROKU) today announced the launch of “Winter StreamLand” on The Roku Channel, an initiative designed to deliver easy access to great entertainment and help users to escape, relax
Iteris Announces Acquisition of TrafficCast International, Inc.
Iteris, Inc. (NASDAQ: ITI), the global leader in smart mobility infrastructure management, today announced its acquisition of TrafficCast International, Inc. (TrafficCast), a privately held company
Del Webb Nocatee Named Best New Active Adult Community of 2020
For the third year in a row, a Del Webb community took top honors in the annual Top 10 Best New Active Adult Communities by 55places.com, an online resource that compares active adult communities
LivaNova Announces Board Appointment and Board Leadership Changes
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a series of enhancements to the Company’s governance.
Todd Schermerhorn has been appointed
Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced it has
Greek Government and Palantir Reaffirm Digital Transformation Partnership
Alex Karp, the co-founder and CEO of Palantir Technologies (NYSE:PLTR), spoke via teleconference on December 3 with Greek Prime Minister Kyriakos Mitsotakis about Palantir’s ever-expanding
GrafTech Announces Commencement of Senior Secured Notes Offering
GrafTech International Ltd. (NYSE: EAF) (GrafTech or the Company) today announced that its wholly owned subsidiary, GrafTech Finance Inc. (GrafTech Finance), has commenced a private offering of
Cloudflare’s Data Localization Suite Gives Global Companies the Tools They Need to Control Data Wherever They Do Business
Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, today released Data Localization Suite to give businesses across the globe tools
Nanobiotix Announces the Start of the Roadshow for Its Proposed Global Offering and Proposed Nasdaq Listing
NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN : FR0011341205 – the “Company”), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the start
Pfizer Reports Positive Clinical Data for BCMA-CD3 Bispecific Antibody (PF-06863135) in Multiple Myeloma
Pfizer Inc. (NYSE:PFE) today announced safety and clinical response results from the ongoing Phase 1 study (NCT03269136) for PF-06863135, an investigational B-cell maturation antigen (BCMA)
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy
Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene
Cannae Holdings, Inc. Announces $350 Million Investment in Foley Trasimene Acquisition Corp. II and Paysafe Merger
Cannae Holdings, Inc. (NYSE:CNNE) (“Cannae” or the “Company”) today announced that the Company, in conjunction with the announced Foley Trasimene Acquisition Corp. II (NYSE: BFT, BFT WS) (“Foley
Fuel Tech Regains Compliance with NASDAQ Minimum Bid Price Requirement
Fuel Tech, Inc. (NASDAQ: FTEK) (or “the Company”), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in
Perion Raises Financial Outlook, Expects 31% Year over Year Revenue Growth in the Fourth Quarter of 2020
Perion Network Ltd. (NASDAQ: PERI), a global technology company that delivers its Synchronized Digital Branding solution across the three main pillars of digital advertising - ad search, social
Technical Outlook of SSE PLC
.png?locale=us "FinanceClub_UoM")
QIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell Response
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the launch of its QuantiFERON SARS-CoV-2 RUO solution that can detect T-cell responses of the human immune system to the
Agilent Presents Thought Leader Award to IIT Delhi Scientist Professor Anurag Rathore
Agilent Technologies Inc. (NYSE: A) has honored Prof. Anurag Rathore, a scientist at the Indian Institute of Technology (IIT) Delhi, with an Agilent Thought Leader Award, for his contributions to
Xencor Presents Updated Data from the Phase 1 Study of Vibecotamab in Acute Myeloid Leukemia at the 2020 ASH Annual Meeting
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced updated data
Durable Clinical Benefits Induced by IMV’s T Cell Therapy in Combination With Merck’s Keytruda in Subjects With PD-L1 Positive r/r DLBCL Presented at ASH Annual Meeting
IMV Inc. (Nasdaq:IMV; TSX:IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases
Weekly Market and Economy Outlook, December 6th 2020